Hudson Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,821
Closed -$3.46M 68
2024
Q1
$3.46M Buy
15,821
+1,031
+7% +$227K 1.19% 42
2023
Q4
$3.36M Buy
14,790
+1,085
+8% +$228K 1.22% 41
2023
Q3
$2.76M Sell
13,705
-1,573
-10% -$332K 1.1% 44
2023
Q2
$3.17M Buy
15,278
+942
+7% +$183K 1.22% 39
2023
Q1
$2.83M Buy
14,336
+697
+5% +$143K 1.12% 42
2022
Q4
$2.76M Buy
13,639
+1,814
+15% +$355K 1.09% 39
2022
Q3
$2.08M Buy
11,825
+1,465
+14% +$300K 1.04% 44
2022
Q2
$2.09M Buy
10,360
+3,416
+49% +$728K 0.99% 42
2022
Q1
$1.57M Buy
6,944
+1,144
+20% +$269K 0.62% 47
2021
Q4
$1.57M Buy
5,800
+1,996
+52% +$494K 0.57% 47
2021
Q3
$920K Buy
+3,804
New +$959K 0.37% 47

Other funds holding LH

Hudson Capital Management's LH Position: Q2 2024 in Review

Hudson Capital Management sold out of Labcorp (LH) in Q2 2024, closing a stake of 15,821 shares — an estimated $3.46M sold.

Hudson Capital Management first reported a position in LH in Q3 2021 and held it in 11 quarters. The position peaked at $3.46M in Q1 2024. 852 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Hudson Capital Management reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Hudson Capital Management sold 15,821 Labcorp shares in Q2 2024, an estimated $3.46M.
  • Hudson Capital Management first reported a position in Labcorp in Q3 2021 and held it in 11 quarters.
  • Hudson Capital Management's Labcorp position peaked at $3.46M in Q1 2024.
  • 852 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Hudson Capital Management's 13F filing for Q2 2024, filed 16 Jul 2024.